Ventyx Biosciences, Inc. — Investor Relations & Filings
Ventyx Biosciences, Inc. is a clinical-stage biopharmaceutical company that develops innovative oral therapies for autoimmune, inflammatory, and neurodegenerative diseases. The company utilizes its expertise in medicinal chemistry, structural biology, and immunology to discover and advance differentiated small molecule therapeutics for conditions with high unmet medical needs. Its clinical pipeline features a portfolio of NLRP3 inhibitors, including VTX2735, a peripherally restricted candidate in Phase 2 development for recurrent pericarditis, and VTX3232, a CNS-penetrant candidate in Phase 2 for neurodegenerative and cardiometabolic diseases. Additionally, its inflammatory bowel disease portfolio includes tamuzimod, an S1P1R modulator, and VTX958, a TYK2 inhibitor, both of which have completed Phase 2 clinical trials.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| 4 - VENTYX BIOSCIENCES, INC. (0001851194) (Filer) | 2026-03-04 | English | |
| 4 - VENTYX BIOSCIENCES, INC. (0001851194) (Filer) | 2026-03-04 | English | |
| 4 - VENTYX BIOSCIENCES, INC. (0001851194) (Filer) | 2026-03-04 | English | |
| 4 - VENTYX BIOSCIENCES, INC. (0001851194) (Filer) | 2026-03-04 | English | |
| 4 - VENTYX BIOSCIENCES, INC. (0001851194) (Filer) | 2026-03-04 | English | |
| 4 - VENTYX BIOSCIENCES, INC. (0001851194) (Filer) | 2026-03-04 | English |
Browse filings by year
6 yearsMarket data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
Medicure Inc
Value-based pharma focused on developing and commercializin…
|
MPH | CA | Manufacturing |
|
Medicus Pharma Ltd.
Develops non-invasive treatments for dermatological conditi…
|
MDCX | CA | Manufacturing |
|
MedinCell S.A.
Pharmaceutical company specializing in long-acting injectab…
|
MEDCL | FR | Manufacturing |
|
MEDINET Co., Ltd.
A CDMO providing one-stop solutions for regenerative medici…
|
2370 | JP | Manufacturing |
|
Medios AG
Wholesale and manufacturing of specialty pharmaceuticals fo…
|
ILM1 | DE | Manufacturing |
|
MediPharm Labs Corp.
A GMP-certified pharmaceutical company producing precision-…
|
LABS | CA | Manufacturing |
|
MEDIPOSTCO.,LTD.
Develops stem cell therapeutics and regenerative medicine f…
|
078160 | KR | Manufacturing |
|
Medistep Healthcare Limited
Develops, manufactures, and distributes pharmaceutical form…
|
MEDISTEP | IN | Manufacturing |
|
Medivir
A pharmaceutical company developing innovative drugs for ca…
|
MVIR | SE | Manufacturing |
|
MediWound Ltd.
Biopharmaceutical firm developing enzymatic therapeutics fo…
|
MDWD | IL | Manufacturing |
Ventyx Biosciences, Inc. via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/33798/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=33798 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=33798 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=33798 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 33798}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for Ventyx Biosciences, Inc. (id: 33798)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.